Healthtech Startups

Sensible Medical develops the ReDS system, a non-invasive monitoring technology that measures lung fluid levels in real-time to help clinicians manage heart failure and fluid-related conditions. The company serves healthcare providers and patients to reduce hospital readmissions and improve disease management.

1 investor

1 investor

Sensible Care provides online and in-person therapy and psychiatry for adults, teens, children, couples, and families, with in-network coverage including TRICARE, Medi-Cal, and Anthem. It offers coordinated care through a secure account and mobile apps, serving patients in California, Texas, and Virginia.

1 investor

Sensifai develops predictive health solutions that use scientific expertise to identify and prevent illness before it occurs. The company serves clinicians, researchers, and patients through technology combining clinical and engineering talent.

1 investor

Sensimed SA develops the SENSIMED Triggerfish, a non-invasive soft contact lens-based device that automatically records continuous ocular dimensional changes over 24 hours to support glaucoma management. The company centralizes and analyzes this data on a registry to help ophthalmologists differentiate indications, personalize treatment, and assess treatment efficacy.

1 investor

Sensocure develops implantable microsensor technology to monitor tissue oxygen levels and detect ischemic events before irreversible damage occurs. The Norwegian medical device company targets clinical applications in tissue monitoring and prevention of ischemic injury.

1 investor

SENSOMATT develops intelligent systems combining IoT sensors, AI, and extended reality for elderly care, rehabilitation, and hospital settings. Its products include smart cushions and mattresses for pressure and fall detection, voice-based cognitive monitoring, and XR-based cognitive training platforms.

1 investor

SensorsCall offers carealert, a sensor-based device and dashboard system that passively monitors the wellness and daily activity of residents such as seniors without requiring input from patients or caregivers. It serves care facilities, remote social services, and medication compliance programs, providing activity trend alerts, intercom communication, and integration with FDA-approved health devices.

1 investor

eShift offers a real-time clinical care coordination platform that lets remote clinicians such as physicians, nurse practitioners, and registered nurses direct care for multiple patients while in-person team members like LPNs, CNAs, and paramedics deliver services at the point of care. The configurable system supports various clinical populations, care settings, and healthcare markets, with a focus on outcomes like hospital avoidance and lower cost per encounter.

1 investor

SensTek Diagnostics develops a solid-state molecular testing platform that enables rapid bacterial, fungal, and viral diagnostics across clinical, agricultural, water, and food safety applications. The company targets improved access to accurate diagnostics for communities underserved by traditional laboratory infrastructure.

1 investor

Sentieon develops optimized bioinformatics algorithms for genomic data processing, particularly for precision medicine applications. The company specializes in variant calling and other secondary analysis tools that process next-generation sequencing data.

1 investor

Sentinal4D develops interpretable machine learning tools for analyzing 3D and 4D cell morphology in drug discovery and mechanistic biology. PointMIL is a framework that classifies static 3D cell point clouds while providing point-level explanations of model predictions, enabling scientists to see where on the cell surface the model finds evidence for biological conclusions.

1 investor

Sentra is an AI-powered platform for post-acute care providers that automates clinical workflows such as referral processing to reduce administrative work and optimize financial outcomes. It targets healthcare organizations and facilities seeking faster, more accurate admissions decisions.

1 investor

1 investor

A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.

1 investor

Seonix develops a genetic risk score to identify individuals at elevated risk of glaucoma, serving eye health professionals, patients, and researchers. The company uses large-scale genetic datasets and advanced techniques for clinical risk prediction to help prevent vision loss.

1 investor

A company developing wearable devices combined with artificial intelligence to detect early signs of sepsis in patients outside hospital settings.

1 investor

Septest develops rapid point-of-need diagnostic tests for detecting infections and inflammation, including its multi-marker TRISEP test aimed at pre-hospital and community triage. The tools are intended for frontline healthcare professionals to speed sepsis detection and reduce antimicrobial resistance, with a focus on accessibility including in low- and middle-income countries.

1 investor

SeqCenter provides DNA sequencing services with an emphasis on data security and biosecurity for research organizations. The company operates U.S.-based infrastructure with secure data handling, chain-of-custody tracking, and encrypted delivery methods.

1 investor

Sequel Med Tech develops wearable insulin delivery devices and precise drug delivery technology for people with diabetes and others, building on the legacy of the insulin pump. The company serves people with type 1 diabetes and healthcare providers, with plans to support drug delivery beyond diabetes.

1 investor

Sequence develops 3D-printed mesh-silicone orthotic insoles combined with objective movement analysis of the kinetic chain (feet through spine), using standing foot scans and dynamic gait data to provide targeted sensory support that helps improve everyday movement. The product is aimed at orthopedic and biomechanical applications, delivered through partner locations.

1 investor

Sequoia Health is a management services organization (MSO) and physician network of over 300 primary care and specialty physicians serving patients in California's Central Valley. It provides technology-enabled operating processes, analytics, and care coordination for affiliated physicians, including a partnership with Golden Valley Health Centers.

1 investor

Sequoia Vaccines develops vaccine treatments for infectious diseases, with a focus on prevention of recurrent urinary tract infections. The company operates in the biotechnology industry with expertise in vaccine development, clinical trials, and manufacturing.

1 investor

Serán is a contract development and manufacturing organization (CDMO) that provides drug formulation, development, and manufacturing services to pharmaceutical companies. The company specializes in process engineering, scaleup, and commercial manufacturing of solid dosage forms and advanced pharmaceutical technologies.

1 investor